The revenue stands at ₹329.67 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 23.82 per cent from ₹432.75 crore. This corresponds to a year-on-year *(YoY) growth of 59.08 per cent.
Operating Profit stands at ₹113.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 38.38 per cent from ₹183.51 crore. This corresponds to a year-on-year *(YoY) growth of 122.10 per cent.
PBDT stands at ₹113.73 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 41.20 per cent from ₹193.43 crore. This corresponds to a year-on-year *(YoY) growth of 71.77 per cent.
Profit Before Tax stands at ₹103.91 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 43.47 per cent from ₹183.80 crore. This corresponds to a year-on-year *(YoY) growth of 78.91 per cent.
Net Profit stands at ₹74.99 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 44.15 per cent from ₹134.28 crore. This represents a 70.39 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Acutaas Chemical | 6.38% | 9.13% | 6.60% | 10.43% | 57.54% | 134.95% |
| Neuland Labs. | 3.51% | 6.02% | 4.60% | 41.61% | 87.27% | 54.27% |
| Rubicon Research | -0.93% | 1.09% | 8.62% | 39.21% | 129.08% | 185.70% |
| Piramal Pharma | -1.70% | 0.09% | 0.12% | 32.92% | 38.10% | 7.17% |
| Granules India | 0.24% | 4.55% | 2.98% | 16.12% | 51.13% | 68.10% |
| Caplin Point Lab | 2.27% | -0.77% | 6.27% | 19.64% | 65.27% | 24.68% |
| Pfizer | -0.94% | -10.43% | -15.65% | -9.62% | -12.15% | -20.01% |
Executive Chairman & M.D. : Nareshbhai Ramjibhai Patel
E D & Wholetime Director : Chetankumar Chhaganlal Vaghasia
E D & Wholetime Director : Virendra Nath Mishra
E D & Wholetime Director : Ram Mohan Rao Locande
Independent Non Exe. Director : Girikrishna Maniar
Independent Non Exe. Director : Hetal Gandhi
Independent Non Exe. Director : Richa M. Goyal
Independent Non Exe. Director : Anita Bandyopadhyay
CS / Compliance Officer / Legal Head : Ekta Kumari Srivastava